We do have Covid19 IgG/IgM Immunoassay rapid tests to fight the pandemic
0

Your Cart is Empty

MA1919

Covid19 IgG/IgM Antibody Rapid POC Test CE-marked

Rapid test immunoassay for Covid19 (Coronavirus) with CE certification available for all countries outside of the United States. IgG and IgM testing of antibodies to the Covid19 virus. Orders of 5000-100,000 preferred.

Contact us for a custom quote

The IgG/IgM antibody rapid test (15 minute readout at the point of care) is immediately available for triage or for the differential diagnosis of Covid19. 

Please contact us at info@maternova.net with "Covid19 Urgent" in the heading.

Details of the IgG/IgM Antibody test

We have researched over 75 tests in the last three weeks for Covid19 and we are partnering to distribute the lowest cost and highest sensitivity/specificity combination. 

While PCR is the gold standard (using a nasal swab to test for the actual genetic material of the virus), these PCR tests are often slower to run and need machinery and specialized staff.  Our Covid19 IgG/IgM antibody tests return results within 15 minutes (and in as little as one minute if strongly positive). 

The Covid19 rapid tests that we are manufacturing are immunoassays, meaning that they detect the antibodies to the Covid19 pathogen.  It is very important that the immunoassays used be developed using SARS-CoV-2 specific proteins. 

Accuracy

The analysis of sensitivity and specificity are as follows for the immunoassay we distribute:

      Sensitivity: 93.4%

      Specificity: 97.7%

Use Case

There are several use cases for a rapid point of care immunoassay, even while maintaining PCR as the gold standard test where available.  As noted by the global diagnostics experts at FIND:

"Although most SARS-CoV-2 testing for diagnosis and confirmation today is performed in central laboratories, we need to continue the effort to provide POC systems with sufficient performance for local confirmation and diagnostic testing far more quickly. Triage testing could be based upon combined clinical presentation and basic clinical test patterns (e.g. CBC and metabolic tests) for COVID-19 versus other respiratory diseases, and should be thoroughly investigated as one option to provide far greater availability and lower cost than current testing, which can be followed with more complex and expensive confirmation tests like RNA assays."

The tests utilize whole blood or serum.

Included in orders

-Rapid test cartridge

-Buffer to add to the whole blood or serum sample

-Capillary tube to collect sample 

-Instructions for use

Not included in orders

-Gloves

-Lancet 

Please contact us at info@maternova.net with "Covid19 Urgent" in the heading.

More Literature on Antibodies and Covid19

"The data presented in this study provide evidence that SARS-CoV-2 infection follows a similar antibody pattern and time course to other viral infections. It also implies that serological testing, in conjunction with other methods of detection, can provide a robust method of diagnosing COVID-19 across early and late stages of infection. Of the types of antibodies measured, total antibody metrics were the most sensitive in detecting SARS-CoV-2 versus IgM or IgG alone.

The strong positive correlation between antibody titer levels after two weeks of symptom onset and clinical severity is also noteworthy. High titers of SARS-CoV-2 total antibodies could be an important risk factor for critical illness, distinct from the previously established risk factors of age, gender, and underlying conditions."  (Text is taken from a longer article by Assay Genie)


 

News & Updates

Sign up to get the latest on sales, new releases and more …

maternal and newborn health news